Skip to main content

Want a detailed portfolio tracker?

STVN
NYSE
$19.15

Stevanato Group Spa (STVN)

Stevanato Group SpA (STVN) is a leading global provider of advanced drug delivery systems, specializing in innovative glass and polymer packaging solutions designed for injectable medications used by the pharmaceutical and biotechnology industries. With a steadfast focus on quality, sustainability, and the adoption of cutting-edge technologies, Stevanato is well-positioned to benefit from the burgeoning demand within the biopharmaceutical sector. The company’s dedication to enhancing the efficiency and reliability of drug administration makes it an attractive proposition for institutional investors looking for opportunities in healthcare innovation and sustainable growth.
Website: https://www.stevanatogroup.com
68 analysts
Buy
Target: $24.45 (+27.68%)

Market Cap

$5.16B

P/E Ratio

31.25

Free Cash Flow Yield

-0.16%

Dividend Yield

0.36%

Price Chart

Valuation
Market Cap$5.16B
P/E31.25
Forward P/E31.95
PEG1.37
P/S4.29
P/B3.10
Profitability
Total Revenue (TTM)$1.39B
Gross Profit (TTM)$406M
EBITDA$340M
Profit Margin10.3%
Operating Margin14.2%
EPS$0.60
Financial Health
Debt-to-Equity29.3%
Free Cash Flow Yield-0.16%
Dividend Yield0.36%
Growth & Risk
EPS 5Y CAGR+7.16%
Revenue 5Y CAGR+10.71%
Beta (5Y)0.87
Sharpe Ratio-0.38